Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators.

Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1.

2.

Ticagrelor in Patients with Stable Coronary Disease and Diabetes.

Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstråle W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbalán R, Cornel JH, Widimský P, Leiter LA; THEMIS Steering Committee and Investigators.

N Engl J Med. 2019 Oct 3;381(14):1309-1320. doi: 10.1056/NEJMoa1908077. Epub 2019 Sep 1.

PMID:
31475798
3.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.

4.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

5.

Edoxaban versus warfarin in patients with atrial fibrillation.

Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators.

N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19.

6.

[Risk factors: microalbuminuria].

Khirmanov VN.

Ter Arkh. 2004;76(9):78-84. Review. Russian. No abstract available.

PMID:
15532384
7.

[Albarel (rilmenidin)--a selective I1 imidazole receptor agonist. Pharmacologic properties and experience in clinical use].

Khirmanov VN.

Ter Arkh. 2003;75(2):85-8. Review. Russian. No abstract available.

PMID:
12685403
8.

[Blood pressure profile in patients with hyper- and hypotension: effect of physiological stresses].

Khirmanov VN, Tiurina TV.

Kardiologiia. 2002;42(7):44-6. Russian.

PMID:
12494112
9.

[Long term results of treatment of hypertrophic cardiomyopathy by permanent dual chamber cardiac pacing].

Khirmanov VN, Iuzvinkevich SA, Domashenko AA, Shal'dakh M.

Kardiologiia. 2002;42(8):46-7. Russian. No abstract available.

PMID:
12494095
10.

[Orthostatic Insufficiency. Clinical and Hemodynamic Characteristics of Patients With Disturbances of Blood Pressure Regulation]

Khirmanov VN, Tiurina TV.

Kardiologiia. 2001;41(12):70-72. Russian. No abstract available.

PMID:
12469107
11.

[Recognition and treatment of malignant neurocardiogenic syncopes].

Khirmanov VN, Tiurina TV.

Ter Arkh. 2002;74(4):78-80. Russian. No abstract available.

PMID:
12043251
12.

Pulsometric study of the functional state of cardiovascular system under conditions provoking neurogenic syncopes.

Nesterov VP, Khirmanov VN, Nesterov SV, Tyurina TV, Burdygin AI.

Bull Exp Biol Med. 2001 Sep;132(3):877-80.

PMID:
11740583
13.

[Efficacy of OSMO-Adalat in patients with arterial hypertension in combination with kinked precerebral arteries].

Khirmanov VN, Tiurina TV, Sorokoumov VA, Zakharova IV.

Ter Arkh. 2001;73(9):24-7. Russian.

PMID:
11642075
14.

[Ischemic disease of the kidneys].

Khirmanov VN.

Ter Arkh. 2001;73(6):61-4. Russian. No abstract available.

PMID:
11521526
15.

[Modelling of myocardial hypertrophy in vitro for solving problems of medicinal correction].

Moiseeva OM, Semenova EG, Polevaia EV, Selivanova GV, Vlasova TD, Khirmanov VN, Pinaev GP.

Tsitologiia. 1998;40(12):1025-30. Russian.

PMID:
10188217
16.

[Comparative study of the level of cardiomyocyte hypertrophy in patients suffering from ischemic heart disease with normal arterial pressure and in hypertension].

Selivanova GV, Vlasova TD, Moiseeva OM, Krutikov AN, Gordeev ML, Khirmanov VN.

Tsitologiia. 1997;39(10):938-45. Russian.

PMID:
9505341
17.

[Changes in the cytochemical and morphometric characteristics of the myocytes in the right heart of the rat in adrenal-regeneration hypertension].

Selivanova GV, Vlasova TD, Khirmanov VN, Krutikov AN.

Tsitologiia. 1995;37(5-6):415-23. Russian.

PMID:
8658971
18.

[The effect of adrenal-regeneration hypertension on protein-nucleic acid metabolism in rat atrial cardiomyocytes].

Selivanova GV, Vlasova TD, Khirmanov VN, Krutikov AN.

Tsitologiia. 1993;35(6-7):51-7. Russian.

PMID:
8266563
19.

[Changes in the concentration of atrial hormone in hypertensive crises].

Khirmanov VN, Kireenkov IS, Berkovich OA, Larionov AA, Kornilov NV, Vasil'ev OA.

Klin Med (Mosk). 1993;71(3):34-6. Russian.

PMID:
8015212
20.

Atrial and digitalis-like natriuretic hormones in essential hypertension under functional loading.

Almazov VA, Khirmanov VN, Scherback AI, Krutikov AN, Danilchenko AR, Kireyenkov IS.

Am J Hypertens. 1992 Jun;5(6 Pt 2):135S-139S.

PMID:
1385963

Supplemental Content

Loading ...
Support Center